WHO Viet Nam

Speech of Dr Angela Pratt at the Scientific Conference on Infectious Diseases and Public Health Issues (Ho Chi Minh City Pasteur Institute)

17 November 2026
Speech
Reading time:

[Please check against delivery]

Let me begin by thanking the Pasteur Institute in Ho Chi Minh City for organizing this important scientific conference and the honour of being invited to speak, and congratulations again on your 135th anniversary.  

Two years ago at this same event, I spoke about several major shifts reshaping public health, many of them converging in Viet Nam:  

  • demographic change and NCDs,  
  • climate change,  
  • antimicrobial resistance, and  
  • emerging and re-emerging infectious diseases.  

Over time, these shifts are only becoming more significant, and so today I'd like to focus on what they mean for the future of public health research. In other words, in a fast-changing world, what kind of public health evidence will we need to navigate an increasingly complex future? 

But before I attempt to answer that question, let me briefly recap on some of the ways the world is changing.  

First, on the importance of demographic change and the growing burden of noncommunicable diseases. 

Viet Nam is one of the fastest-ageing societies in the world. At the same time, noncommunicable diseases are accounting for an increasing share of illness, disability and death. In other words, people are living longer – but in the last few years of life in particular, they are not always living well.  

On one hand, these twin trends – ageing and NCDs – reflect remarkable progress. After all, population ageing is fundamentally good news. But on the other hand, the growing burden of NCDs is creating demands on health services that the health system is not currently set up to deliver. 

So the question is how we help people not only live longer, but also stay healthy for longer – this is the key to how our health and care systems must transform to meet the needs of an ageing population. 

Demographic and epidemiological change is not occurring in isolation. It is unfolding along with another profound shift with major, intersecting implications for public health: climate change. 

We are already seeing the effects of climate change on health through more extreme weather – extreme heat and frequent natural disasters, floods and droughts, threats to food and water security, and changing patterns of infectious disease.  

This trend is not going to change. Instead, it demands that we think differently about preparedness, resilience and how to protect health in a changing climate.  

We also face the growing threat of antimicrobial resistance, or AMR. 

This is probably the issue that most often keeps me awake at night, because AMR quite literally threatens to undermine decades of medical progress. I have experienced the impacts of AMR first-hand: one of my daughters has now experienced several severe, antibiotic-resistant infections – infections that once would have been easily treated with first-line antibiotics when I was a child. Increasing rates of AMR have implications not only for infectious disease, but also for surgery, cancer treatment, and maternal and child health. 

Fourth, together with AMR, we are still facing emerging and re-emerging infectious disease threats, which continue to threaten health security.

As human, animal and environmental systems become increasingly interconnected, understanding, preparing for, and responding to dynamic disease threats – in particular including zoonoses – will remain a critical public health priority. 

These shifts – demographic change and NCDs, climate change, AMR and the ever-present threat of emerging and re-emerging infectious diseases – are all unfolding in a world that is becoming more interconnected, more global, but also more complex. People, goods, information and pathogens move around the world faster than ever before. As a result, expectations around preparedness and health security continue to evolve. And no country can address today's health challenges alone – regional and global collaboration are becoming ever-more important. 

Implications for research  

So, now this brings me to the question of what kind of evidence we need to help us navigate this complex future? That is, what kind of research will help us answer questions like: 

  • What models of service delivery and care will best support healthy ageing?
  • How can we better predict and respond to climate-sensitive diseases?
  • How can countries strengthen health system resilience in an uncertain world?
  • How can we slow the emergence and spread of antimicrobial resistance?
  • And – perhaps most importantly – how can we ensure that evidence reaches decision-makers quickly enough to make a difference? 

Answering these questions will not be easy. But there is reason for optimism. Because many of the tools available to researchers today were beyond imagination only a few decades ago.  

For example, advances in medical science, surveillance and research are accelerating our ability to understand disease and develop new interventions. A generation ago, identifying and characterizing a new pathogen could take months or years. Today, genomic sequencing and other advanced molecular testing – like that which is done here at PI HCMC – can help track emerging pathogens in real time, informing public health responses around the world. 

Diseases once life-threatening are now routinely preventable, curable or at least manageable. Conditions such as HIV, hepatitis C and many cancers have been transformed by advances in medicines, diagnostics and vaccines over the past few decades.   

In addition, digital technologies, including artificial intelligence, are transforming the way we protect and improve people's health. Technology is strengthening surveillance, improving health information systems, expanding access to and quality of clinical care, and helping us identify health threats earlier, enabling faster and more effective responses.  

Our ability to understand and respond to the shifting public health landscape has never been greater. But innovation is not an end in itself. Its value lies in whether it helps us save lives, reduce inequities and improve population health. Technology should serve people, helping us build healthier, more resilient societies.  

So what does all of this mean for the kind of public health research we most need now? Let me pose four thoughts.  

First, we need research that looks ahead. 

In other words, research that helps governments see around corners and prepare for what lies ahead, rather than react to what is in front of us right now. The world is changing too fast to only focus on the problems of today. We need research and evidence which better helps us anticipate – and prepare for – the range of threats to public health that will continue to emerge in the future.  

Second, we need collaborative research. 

The most significant public health challenges rarely fit neatly into a single field of expertise. To understand the full dimensions of a challenge like hypertension – and how to effectively address it – we need to bring together epidemiologists, biostatisticians, health systems experts, behavioural scientists and implementation researchers. And more broadly, responding effectively to challenges like the health impacts of climate change will only come from working together across health, science, environment, meteorology, economics, social science, government and many other fields. 

Third, we need research that moves more rapidly into policy and practice. 

Too often – and I see this in so many areas – a gap remains between evidence and implementation. We need to close these gaps, through stronger partnerships between researchers and policymakers. Research should help answer real-world policy questions. And evidence needs practical pathways to inform decision-making. 

Because even the best evidence, the most innovative technologies and the strongest policies will not improve health if they are not effectively translated into changes which make a difference to whether someone can access the health service they need, or the drug that will help cure their disease.  

Underlying all of these priorities is one further principle – which to my mind is probably the most important one. 

We need research that keeps equity at its centre. 

Public health has always been grounded in a simple principle: that everyone should have the opportunity to achieve good health. It is what WHO means when we talk about “Health For All”. When we assess new technologies, new interventions or new research findings, we should always ask: 

  • Who benefits? 
  • Who doesn’t? 
  • Who is being left behind? 
  • And what can we do about it? 

Because the true test of innovation is not novelty – it is impact. Research succeeds when it changes lives for the better. 

Of course, none of the ideas or principles I have just shared are new. Researchers and public health leaders have discussed them for many years. Many of you are probably already doing this things. So my humble suggestion is that what is important now is that we really prioritize these principles, invest in them, and apply them in ways that match the scale of the public health shifts we are experiencing, and will continue to experience in the future.  

These principles I have just shared are global. But they also raise an important question: which countries are best positioned to help lead this next phase of public health research and innovation? 

Viet Nam’s role  

I believe Viet Nam is well placed to be one of those countries. 

Viet Nam has strong scientific institutions, growing research capacity, deep experience in infectious disease control, and an increasingly influential voice in regional and global health. 

More and more, Viet Nam is becoming not only as a user of health innovations developed elsewhere, but a contributor to global knowledge and innovation – as demonstrated by pictures like this one, of the National Hospital for Tropical Diseases in Hanoi being designated as a WHO Collaborating Centre.  

Through collaborations like this one, investments in clinical research, biotechnology, vaccine manufacturing using new technology, digital health and artificial intelligence, Viet Nam is building capabilities that can improve health for its own people while also generating benefits for the region and the world. 

Conclusion  

Let me conclude with one final thought. The tools, technologies and health challenges before us will continue to evolve. But the fundamental purpose of public health remains unchanged. It is to protect lives, prevent disease, reduce inequities and create the conditions that enable people to live healthier lives. 

Research is one of the most powerful tools we have to achieve that goal. 

And so we should keep in mind – behind every dataset, every surveillance system, every laboratory result and every research paper – the people who public health is for. The child protected from an infectious disease. The young person who is fit, healthy and living their best life. The older person who can live healthier for longer. The family spared the financial and emotional burden of serious illness. The community protected from the worst impacts of an extreme weather event, or a pandemic threat. 

That is why public health research matters. Not because it advances science for its own sake, but because it helps people live healthier, safer, more productive and more fulfilling lives. 

Throughout this speech I have spoken about the shifts that are reshaping health and the evidence we will need to navigate them.  

As we adapt to a rapidly changing world, I hope you will agree that these principles should remain our compass: prevention first, equity always, and science in the service of people. 

Xin cảm ơn!